The Electronic Patient Visit Assessment (ePVA) and Nationwide Children’s Hospital Named Awardees in Johnson & Johnson Nurses Innovate QuickFire Challenge in Oncology

May 28, 2020 -
3 months ago
Other news

June 9, 2020 — In honor of Oncology Nursing Month, Johnson & Johnson Innovation – JLABS, together with the Oncology Nursing Society (ONS), announced today that the Electronic Patient Visit Assessment (ePVA) of the NYU Rory Meyers College of Nursing and Nationwide Children’s Hospital have been selected as the awardees in Johnson & Johnson Nurses Innovate QuickFire Challenge in Oncology. The Challenge was designed with the aim to accelerate innovation in improving oncology care including prevention, early detection, treatment and care for cancer survivors.

To advance their research, The Electronic Patient Visit Assessment and Nationwide Children’s Hospital will receive a combined total of $100,000 in grant funding and access to the Johnson & Johnson Innovation – JLABS ecosystem.

The Electronic Patient Visit Assessment (ePVA) of NYU Rory Meyers College of Nursing: The Electronic Patient Visit Assessment (ePVA) is a digital health platform for capturing patient-reported symptoms of cancer treatment, enabling real-time interventions and capturing clinical & quality data for reimbursement.

The Nationwide Children’s Hospital: The Nationwide Children's Hospital team has developed a mobile application for capturing the entire symptom experience of children with cancer in an interactive and fun interface, enabling personalized interventions and care.

Johnson & Johnson Innovation- JLABS' QuickFire Challenges are competitions designed to attract and support the most promising life science innovators in their quest to advance breakthrough science addressing unmet medical and healthcare needs. Awardees can receive grant funding, mentorship and the opportunity to become residents at JLABS to move their science forward. To date over 45 QuickFire Challenges have launched with over 3,700 applications and innovators have received more than $8 million in awards.

About Johnson & Johnson Innovation

Johnson & Johnson Innovation, LLC focuses on accelerating all stages of innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson’s global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies with one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer companies of Johnson & Johnson. Under the Johnson & Johnson

Innovation umbrella of businesses, we connect with innovators through our regional Innovation Centers; Johnson & Johnson Innovation—JLABS; Johnson & Johnson Innovation – JJDC, Inc.; and our business development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs in patients. JLABS provides the laboratories, expertise, education, tools and resources needed to help life science startups thrive, all with no strings attached. A Johnson & Johnson Innovation Center for Device Innovation at the Texas Medical Center (CDI @ TMC) has been established to accelerate the development of medical devices. For more information about Johnson & Johnson Innovation, please visit: www.jnjinnovation.com.

About Johnson & Johnson Innovation—JLABS

Johnson & Johnson Innovation – JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators across a broad healthcare spectrum including pharmaceutical, medical device, consumer and health tech sectors to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS, we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS also produces campaigns to seek out the best science called QuickFire Challenges. For more information, visit www.jlabs.jnjinnovation.com or follow @JLABS.

About Johnson & Johnson Nursing

Johnson & Johnson has supported the nursing profession for over 120 years because we believe nurses are uniquely positioned to change the global trajectory of health for humanity. Nurses, over 29 million strong[1], are our critical partners on the front lines of care and are the backbone of healthcare systems around the world. As we work to change the trajectory of health for humanity, Johnson & Johnson is proud to support and elevate the visibility and impact of nursing by championing nurse-led innovation, supporting skills development, developing nurse leaders and strengthening nurse resiliency. We are committed to advocating for, and empowering nurses globally as critical drivers of better health outcomes. Together with our partners, Johnson & Johnson is proud to shine a spotlight on nurses and their impact, and directly empower their work, because we believe they are, and have always been, catalysts to changing the trajectory of health for humanity. Nurses change lives. And that changes everything.

About the Oncology Nursing Society (ONS)

ONS is a professional association of more than 35,000 members committed to promoting excellence in oncology nursing and the transformation of cancer care. Since 1975, ONS has provided a professional community for oncology nurses, developed evidence-based education programs and treatment information, and advocated for patient care, all in an effort to improve quality of life and outcomes for patients with cancer and their families. Learn more at www.ons.org.

[1] World Health Statistics 2013


Related content